|
May 13
|
Trevi Therapeutics, Inc. (NASDAQ:TRVI) Q1 2024 Earnings Call Transcript
|
|
May 9
|
Trevi Therapeutics to Participate in Upcoming Conferences
|
|
May 8
|
Q1 2024 Trevi Therapeutics Inc Earnings Call
|
|
May 7
|
Trevi Therapeutics Reports Q1 2024 Financial Results: A Detailed Analysis
|
|
May 7
|
Trevi Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
|
|
May 1
|
Trevi Therapeutics to Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 7, 2024
|
|
Apr 18
|
Trevi Therapeutics (TRVI) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
|
|
Apr 9
|
Trevi Therapeutics Announces Abstract Presentation at the American Thoracic Society 2024 International Conference
|
|
Apr 4
|
Why Trevi Therapeutics (TRVI) Stock Might be a Great Pick
|
|
Apr 4
|
Trevi Therapeutics to Participate in Upcoming April Events
|
|
Apr 2
|
Trevi Therapeutics Adds Clinical Development Expertise in Chronic Cough to Leadership Team
|
|
Mar 21
|
Trevi Therapeutics, Inc. (NASDAQ:TRVI) Q4 2023 Earnings Call Transcript
|
|
Mar 20
|
Trevi Therapeutics Inc (TRVI) Announces Year-End Financials and Progress in Clinical Trials
|
|
Mar 20
|
Trevi Therapeutics Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Updates
|
|
Mar 13
|
Trevi Therapeutics to Report Q4 and Year End 2023 Financial Results and Provide a Corporate Update on March 20, 2024
|
|
Feb 29
|
private equity firms who own 35% along with institutions invested in Trevi Therapeutics, Inc. (NASDAQ:TRVI) saw increase in their holdings value last week
|
|
Feb 28
|
Trevi Therapeutics to Participate in Upcoming March Events
|
|
Feb 6
|
Trevi Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
|
|
Dec 5
|
Trevi Therapeutics Announces the Initiation of its Phase 2b CORAL Clinical Trial of Haduvio™ for Chronic Cough in Idiopathic Pulmonary Fibrosis (IPF)
|
|
Nov 30
|
Down -38.07% in 4 Weeks, Here's Why You Should You Buy the Dip in Trevi Therapeutics, Inc. (TRVI)
|